Provided by Tiger Fintech (Singapore) Pte. Ltd.

Celularity Inc.

1.67
+0.13008.44%
Post-market: 1.670.00000.00%16:05 EDT
Volume:162.43K
Turnover:270.81K
Market Cap:39.76M
PE:-1.01
High:1.76
Open:1.58
Low:1.55
Close:1.54
Loading ...

Celularity receives FDA TRG recommendation letters for Natalin, Acelagraft

TIPRANKS
·
25 Feb

Celularity Receives FDA Tissue Reference Group Recommendation Letters for Its Natalin and Acelagraft™ Wound Care Products

THOMSON REUTERS
·
25 Feb

Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products

GlobeNewswire
·
25 Feb

Celularity Inc - Agreement to Initially Focus on Production of Bsb's Novel Tcr T Cell Therapies

THOMSON REUTERS
·
24 Feb

Celularity Inc - Enters Collaboration Agreement With Bluesphere Bio

THOMSON REUTERS
·
24 Feb

Celularity Enters Strategic Collaboration Agreement With Clinical Stage Cell Therapy Company

THOMSON REUTERS
·
24 Feb

BRIEF-Celularity Inc - On Feb 12, Enters Binding Term Sheet Or Rwi Binding Term Sheet, With Resorts World Inc Pte Ltd

Reuters
·
18 Feb

Celularity Inc - Rwi Extends Maturity Date of $27 Million Loans to 2026

THOMSON REUTERS
·
18 Feb

Celularity Inc - on Feb 12, Enters Binding Term Sheet or Rwi Binding Term Sheet, With Resorts World Inc Pte Ltd

THOMSON REUTERS
·
18 Feb

MASS Coalition Welcomes Trump Order Freezing Skin Substitute LCDs

GlobeNewswire
·
27 Jan

Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter

THOMSON REUTERS
·
10 Dec 2024

Celularity Inc. Announces Resolution of Nasdaq Listing Compliance Matter

GlobeNewswire
·
10 Dec 2024

Celularity Reports Over Sevenfold Growth in Net Product Sales Through Third Quarter 2024 Compared to Third Quarter 2023

THOMSON REUTERS
·
06 Dec 2024

Celularity Inc: Filed Quarterly Report on Form 10-Q for Period Ended Sept 30, & NOW Current With Quarterly Report Filings

THOMSON REUTERS
·
06 Dec 2024

Press Release: Celularity Reports Over Sevenfold Growth in Net Product Sales through Third Quarter 2024 Compared to Third Quarter 2023

Dow Jones
·
06 Dec 2024

BRIEF-Celularity Announces Receipt Of Nasdaq Notification

Reuters
·
28 Nov 2024